| Code |
Title |
Intervention |
Sponsor |
Therapeutic
Indication |
 |
| NEB-01/99-CH |
Changes in Peak Respiratory Flow and quality of Life during nebivolol therapy
|
Nebivolol
|
Menarini Switzerland
|
Hypertension |
|
| NEB/CLIN/CH-12/99 |
Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilatation
|
Nebivolol versus Atenolol
|
Menarini Switzerland
|
Healthy Volunteers |
|
| MK1MEN |
A comparison of the beta1-selecivity of three beta1-selective MK1MEN beta-blockers
|
Nevivolol versus Atenolol, Bisoprolol
|
Menarini Pharmaceutical U.K.
|
Healthy Volunteers |
|
| NEB/RP/02 |
Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre,double-blind study
|
Nebivolol versus Lisinopril
|
Menarini Ifr
|
Hypertension |
|
| NEB/CLIN/NL-3/97 |
Comparison of effect on systolic and diastolic left ventricular function of Nebivolol versus Atenolol in patients with uncomplicated essential hypertension
|
Nebivolol versus Atenolol, Bisoprolol
|
Menarini Benelux
|
Hypertension |
|
| MR/01-99/01-NHF |
Randomized trial to determine the effectof nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
|
Nebivolol from 1,25 to 10mg/day
|
Menarini Ricerche
|
Heart Failure |
|
| IC03/00/DKP |
Comparison of intravenous dexketoprofen and dipyrone in acute renal colic
|
phase I : Dexketoprofen trometamol 25 mg intravenous route Dexketoprofen 50 mg intravenus route versus Dipyrone 2g/5ml; phase II Dexketoprofen trometamol Dipyrone 575 mg
|
Laboratorios Menarini S.A
|
Acute Renal Colic |
|
| MeAR/03/Neb-End/001 |
A single center, open study of Nebilet 5 mg to evaluate the change in the cold test as a marker of the endothelial dysfunction change (EDEN I)
|
Nebivolol,
5 mg
|
Laboratorios Menarini Argentina S.A.
|
Hypertension |
|
| LUMI/06/FRO-MIG/001 |
A patient preference study of frovatripitan versus rizatriptan for the acute treatment of migraine
|
Frovatriptan 2.5 mg
Vs
Rizatriptan 10 mg
|
Istituto Lusofarmaco d’Italia S.p.A.
|
Migraine |
|
| LUMI/06/FRO-MIG/002 |
Frovatriptan Versus Zolmitriptan in the Treatment of Migraine with or without Aura: a Patient Preference Study
|
Frovatriptan 2.5 mg
Vs
Zolmitriptan 2.5 mg
|
Istituto Lusofarmaco d’Italia S.p.A.
|
Migraine |
|
| OLM/CLIN/I-12/03 (ESPORT) |
Efficacy and Safety of Olmesartan in elderly patients with mild to moderate hypertension
|
Olmesartan 10 or 20 or 40 mg o.d.
Vs
Ramipril 2.5 or 5 or 10 mg o.d.
|
Malesci Istituto Farmacologico S.p.A / Laboratori Guidotti S.p.A
|
Hypertension |
|
| MeRo/04/Neb-LVD/001 |
Effects of Nebivolol on Subclinical left ventricular dysfunction. A comparative study against Metoprolol. (ENESYS)
|
Nebivolol,
5 mg,
tablets, qd
Vs
Metoprolol
50 mg, bid
|
Berlin-Chemie AG
|
Hypertension and Left Ventricular Dysfunction |
|
| MeBN/02/Neb-PCI/002 |
Nebivolol inhibition of coronary artery Smooth muscle cell proliferation after Coronary artery InterventiOn (NESCIO)
|
Nebivolol,
5 mg o.d.,
tablets
Vs
Metoprolol
100 mg o.d.
|
Menarini Benelux SA/NV
|
Angina pectoris post Acute Myocardial Infarction |
|
| MeBN/02/Neb-DHF/001 |
Effects of The Long-Term Administration Of Nebivolol on the Clinical Symptoms, Exercise Capacity And Left Ventricular Function Of Patients With Diastolic Dysfunction (ELANDD)
|
Nebivolol,
2,5 or 5 or 10 mg o.d.,
tablets
Vs
Placebo
|
Menarini Benelux SA/NV
|
Heart Failure |
|
| MeTK/CLIN/NEB/ HYPERTROPHY/03/001 |
Effects of Nebivolol and Ramipril on Left Ventricular Hypertrophy, Quality of Life and Blood Pressure in patients with mild to moderate hypertension associated to Left Ventricular Hypertropy
|
Nebivolol 5 mg/ die
Vs
Ramipril 5mg/die
|
I.E Ulagay Ilac Sanayii Turk AS
|
Hypertension Left ventricular Hypertrophy |
|
| BCBe/04/Neb-Car/082 |
Comparison of the effects of combined rate and rhythm-control treatment with Nebivolol and electric cardioversion to rate- control treatment with Nebivolol alone on clinical and echocardiographic parameters in patients with Left ventricular dysfunction induced by tachycardia
|
Nebivolol 5 mg/ die
Vs
Electric cardioversion
|
Berlin Chemie AG
|
Hypertension and Arrhythmia |
|
| BCBe/04/Neb-Gla/081 |
Influence of Nebivolol on Ocular perfusion in patients with Glaucoma and arterial
hypertension.
|
Nebivolol
5 mg o.d.
Vs
Bisoprolol
5 mg o.d.
|
Berlin Chemie AG
|
Hypertension and Glaucoma |
|
| ABA-01 |
A Randomized, Double Blind, Placebo Controlled, Multicentre Trial of Abagovomab Maintenance Therapy in Patients with Epithelial Ovarian Cancer After Complete Response to First Line Chemotherapy
|
Abagovomab
2 mg/ml subcutaneous
Vs
Placebo subcutaneos
|
Menarini Ricerche S.p.A
|
Ovarian Cancer |
|
